Galmed Pharmaceuticals Ltd. (GLMD)
Nasdaq: GLMD · Pharmaceutical Preparations · Ramat Gan, IL · filing with the SEC since 2013
Who runs Galmed Pharmaceuticals Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Baharaff Allen
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
9 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Baharaff Allen | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Cohen Doron Leib | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
| Nehemya Guy | Chief Operating Officer | Mar 2026 | Mar 18, 2026 | none |
| Nissimov Brueck Liat | Chief Scientific Officer | Mar 2026 | Mar 18, 2026 | none |
| Stenzler Yohai | Chief Accounting Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Brosgart Carol L | director | Mar 2026 | Mar 18, 2026 | none |
| Nir Shmuel | director | Mar 2026 | Mar 18, 2026 | none |
| Poshinski Amir | director | Mar 2026 | Mar 18, 2026 | none |
| Sidransky David | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.